Use of safinamide for treatment of Parkinson disease: real-world data from Spain by María Isabel Morales Casado, Nuria López Ariztegui

Get full text

Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial by Alejandro Rodríguez-Molinero, Carlos Pérez-López, Nuria Caballol, Mariateresa Buongiorno, María Asunción Ávila Rivera, Núria López Ariztegui, Lydia López-Manzanares, Jorge Hernández-Vara, Àngels Bayes-Rusiñol, Alexandre Gironell Carreró, María Álvarez Saúco, Elisabet Franquet Gomez, David A. Pérez-Martínez, Sonia Escalante Arroyo, Silvia Martí-Martínez, Pablo Mir, José Mª Salom Juan, Juan Carlos Martínez-Castrillo, Cristian Tebé, On behalf of the MoMoPa-EC Research Group

Get full text

Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson’s Disease by Diego Santos-García, Lydia López-Manzanares, Inés Muro, Pablo Lorenzo-Barreto, Elena Casas Peña, Rocío García-Ramos, Tamara Fernández Valle, Carlos Morata-Martínez, Raquel Baviera-Muñoz, Irene Martínez-Torres, María Álvarez-Sauco, Déborah Alonso-Modino, Inés Legarda, María Fuensanta Valero-García, José Andrés Suárez-Muñoz, Juan Carlos Martínez-Castrillo, Ana Belén Perona, Jose María Salom, Esther Cubo, Caridad Valero-Merino, Nuria López-Ariztegui, Pilar Sánchez Alonso, Sabela Novo Ponte, Elisa Gamo Gónzález, Raquel Martín García, Raúl Espinosa, Mar Carmona, Cici Esmerali Feliz, Pedro García Ruíz, Teresa Muñoz Ruíz, Beatriz Fernández Rodríguez, Marina Mata Alvarez-Santullano

Get full text